Clinical trials
Sleep Apnea, Obstructive trials in Australia with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2019 | 1 |
| 2020 | 5 |
| 2022 | 4 |
| 2023 | 3 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Recruiting | 4 |
| Terminated | 3 |
| Not yet recruiting | 2 |
| Unknown status | 2 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ResMed | 20 |
| Invicta Medical Inc. | 3 |
| Nyxoah S.A. | 2 |
| Woolcock Institute of Medical Research | 2 |
| Compumedics Limited | 1 |
| Fisher and Paykel Healthcare | 1 |
| Restera, Inc. | 1 |
| Sleepy, Inc | 1 |
| StimAire Australia Pty Ltd | 1 |
| The Queen Elizabeth Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sleep Apnea, Obstructive | 34 |
| Sleep Apnea Syndromes | 6 |
| Sleep Wake Disorders | 3 |
| Apnea | 1 |
| Cognitive Dysfunction | 1 |
| Dementia | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Glucose Intolerance | 1 |
| Insulin Resistance | 1 |
| Pulmonary Disease, Chronic Obstructive | 1 |
Trials
Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.